NASCAR Nextel Cup #10 Stanley Race Car to Be on Display at The Leukemia & Lymphoma Society's Riding For A Reason Charity Ride

CORINTH, Texas, March 15 -- The North Texas chapter of The Leukemia & Lymphoma Society will be hosting the first Riding For A Reason Charity Ride on Saturday, April 8, 2006 at American Eagle Harley- Davidson/Buell in Corinth, Texas. NASCAR fans will enjoy the thrill of viewing the Nextel Cup #10 Stanley Race Car, driven by Scott Riggs. The car will be on display from 10 a.m. to 3 p.m. at American Eagle Harley- Davidson/Buell. Motorcycle charity ride registration begins at 9 a.m., rain or shine, and is open to all motorcycle riders. The last bike out is at 10:30 a.m. For a $20 donation, riders start at the Harley dealership, and collect raffle tickets along a route in North Texas. Each stop along the route will provide the rider with directions to the next venue, along with five additional raffle tickets.

Riders must complete the route by 2 p.m. and enter their collected raffle tickets for chances to win several great prizes, including the grand prize -- two tickets to the Samsung/RadioShack 500 Nextel Cup race at Texas Motor Speedway. Tickets include entrance to the hospitality tent and a pit tour. Rolling tool boxes from Stanley Vidmar and MAC Tools, and autographed NASCAR items from Ray Evernham Sports and Joe Gibbs Racing, are also among the list of raffle prizes.

The first 100 riders to register for the event will receive a free gift. Interested motorcycle enthusiasts can pre-register at American Eagle Harley- Davidson/Buell on Saturday, March 25 from 10 a.m. to 2 p.m. Riders may also register by contacting Michele Story at (800) 800-6702, ext. 8321. One hundred percent of proceeds benefit The Leukemia & Lymphoma Society.

The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The Society's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and to improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $424 million for research specifically targeting blood cancers to over 425 researchers in 120 institutions worldwide. Society-funded research has led to key advances in understanding blood cancers and has produced new treatments to enhance and prolong lives. Innovations in cancer treatment over the years have included radiation and chemotherapy, stem cell transplantation and new targeted therapies that kill cancer cells without harming normal cells.